Efficacy of chlorhexidine gluconate rinse for treatment and prevention of oral candidiasis in HIV-infected children: A pilot study

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 97, Issue 2, 2004, Pages 204-207

  Barasch, Andrei ^a   Safford, Monika M ^b   Dapkute Marcus, Ingrida ^c   Fine, Daniel H ^d  

^a UNIVERSITY OF DETROIT MERCY   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE GLUCONATE;

ADOLESCENT; ADULT; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOUTH EXAMINATION; MOUTH MUCOSA;

EID: 1242328956     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2003.09.005     Document Type: Article

References (25)

1. Barasch A., Safford M.M., Catalnotto F., Fine D.H., Katz R.V. Oral soft tissue manifestations in HIV-positive vs. HIV-negative children from an inner city population a two-year observational study . Pediatr Dent. 22:2000;215-220.
2. Katz M., Mastrucci M., Leggott P., et al. Prognostic significance of oral lesions in children with perinatally aquired human immunodefficiency virus infection. AJDC. 147:1993;45-48.
3. Ketchem L., Berkowitz R., McIlveen L., Forrester D., Rakusan T. Oral findings in HIV-seropositive children. Pediatr Dent. 12:1990;143-146.
4. Fetter A., Partisani M., Koenig H., Lang J.M. Asymptomatic oral candida albicans carriage in HIV infection frequency and predisposing factors . J Oral Pathol Med. 22:1993;57-59.
5. Samaranayake L.P., Holmstrup P. Oral candidiasis and human immunodefficiency virus infection. J Oral Pathol Med. 18:1989;554-564.
6. Greenspan D. Treatment of oral candidiasis in HIV infection. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 78:1994;211-215.
7. Baily G., Perry F., Donning D., Mandal B. Fluconazole-resistant candidosis in an HIV cohort. AIDS. 8:1994;787-792.
8. Redding S.W., Kirkpatrick W.R., Dib O., et al. The epidemiology of nonalbicans Candida in oropharyngeal candidiasis in HIV patients. Spec Care Dent. 20:2000;178-181.
9. Johnson E.M., Warnock D.W., Luker J., Porter S.R., Scully C. Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidiasis. J Antimicrob Chemother. 35:1995;103-114.
10. Kelly SL, Lamb DC, Kelly DE, Loeffler J, Einsele H. Resistance to fluconazole and amphoteracin B in C. albicans from AIDS patients. Lancet 1998; 348:1523-4.
11. Tempro P.J., Barasch A., Mickulski L. Antifungal susceptibility of candida isolates from HIV-positive adults. J Dent Res. 77:1998;301.
12. Physicians' Desk Reference. 55th ed. Montvale (NJ): Medical Economics; 2001.
13. Epstein J., Vickars L., Spinelli J., Reece D. Efficacy of chlorhexidine and nystatin rinses in prevention of oral complications in leukemia and bone marrow transplantation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 73:1992;682-689.
14. Ellepola A.N.B., Samaranayake L.P. In vitro post antifungal effect (PAFE) elicited by chlorhexidine gluconate on oral isolates of Candida albicans. Microb Ecol Health Dis. 11:1999;143-148.
15. Warnakulasuriya K.A.A.S., Samaranayake L.P., Peiris J.S.M. Angular cheilitis in a group of Sri Lankan adults. J Oral Pathol Med. 20:1991;172-175.
16. Scully C., El-Kabir M., Samaranayake L.P. Candida and oral candidosis a review . Crit Rev Oral Biol Med. 5:1994;125-157.
17. Flanagan M.A., Barasch A., Koenigsberg S.R., Fine D.H., Houpt M. Prevalence of oral soft tissue lesions in HIV-infected minority children treated with highly active antiretroviral therapies. Pediatr Dent. 22:2000;287-291.
18. Odds F.C. Candida and candidosis. A review and bibliography. 1994;Balliere, Tindal, London.
19. Klepser ME, Ernst EJ, Pfaller MA. Update on antifungal resistance. Trends Microbiol 1994,5:372-5.
20. Maenza J.R., Merz W.G., Romagnoli M.J., Keruli J.C., Moore R.D., Gallant J.E. Infection due to fluconazole-resistant candida in patients with AIDS prevalence and microbiology . Clin Infect Dis. 24:1997;28-34.
21. Le Guennec R., Reynes J., Mallie M., et al. Fluconazole and itraconazole-resistant C. albicans strains from AIDS patients multilocus enzyme electrophoresis analysis and antifungal susceptibilities . J Clin Microbiol. 33:1995;2732-2737.
22. Samaranayake L.P., McFarlane T.W. A retrospective study of patients with recurrent chronic atrophic candidosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 52:1981;150-153.
23. Audus K., Tavalikoli-Saberi M., Zheng H., Boyce E. Chlorhexidine effects on membrane lipid domains of human buccal epithelial cells. J Dent Res. 71:1992;1298-1303.
24. Boyle B.A. Recent advances in HIV clinical research. AIDS Reader. 9:1999;598-608.
25. Miller L.G., Hays R.D. Adherence to combination antiretroviral therapy synthesis of the literature and clinical implications . AIDS Reader. 3:2000;177-184.